11 Apr. 2019
BREAKING THROUGH THE WALL
The follow-up report for the German GUARD Initiative (Global Union for Antibiotics Research and Development), has been published. Report here (Engl...
11 Apr. 2019
BEAM ALLIANCE / BIOCOM AG PRESS RELEASE
SMEs call for improved conditions in AMR drug development Press release here
11 Apr. 2019
ANTIBIOTIKADEBATTE: DRINGEND GESUCHT: NEUE ANTIBIOTIKA
Antibiotikaresistenzen greifen immer mehr um sich..... Der Bedarf an neuen Wirkstoffen ist gross See also the Berlin Conference on Novel Antimi...
11 Apr. 2019
WIRKSTOFFFORSCHUNG: RESISTENZBRECHER DRINGEND GESUCHT
Die Antibiotikaforschung in Mitteleuropa hat unverkennbar an Dynamik gewonnen.
Recent Media Feeds
- Press Release - BioVersys hires new CDO, Dr. Glenn Dale
- Eurostars Funds IMPACT2 Press Release
- Dr. Gitzinger will be speaking at the UNCTAD/WHO event in Geneva, October 23rd, 2018 from 14:30-17:30 on Fostering investment in the development of new antibacterial treatments
- CARB-X welcomes UK Government and Bill & Melinda Gates Foundation as new partners
- BioVersys successfully closes Series A2 financing round
- October 20th, 2017; BioVersys and Marc Gitzinger were featured in the 3Sat news.
- BEAM Alliance fordert G20 Staaten zu mehr Unterstützung im Kampf gegen tödliche Superkeime auf
- Swiss biopharma BioVersys is collaborating with drug discovery and development CRO Aptuit on the discovery and development of new targets and drug candidates against Gram-negative bacteria, including drug-resistant strains. An existing BioVersys target will be included in the partnership.
- Press Release BEAM Alliance / Biocom AG
- Breaking through the Wall ... A Call for Concerted Action on AB Research and Development
